(Q42492424)

1 November 2017

title

Combined 5-HT2/D2 receptor blockade inhibits the firing rate of SNR neurons in the rat brain (English)

1 reference

1 November 2017

1

1 reference

1 November 2017

Heeringa M

2

1 reference

1 November 2017

Westerink BH

series ordinal

3

1 reference

1 November 2017

Timmerman W

series ordinal

4

1 reference

1 November 2017

publication date

1 May 2000

1 reference

Progress in Neuro-Psychopharmacology & Biological Psychiatry

1 November 2017

published in

1 reference

1 November 2017

volume

24

1 reference

1 November 2017

issue

4

1 reference

1 November 2017

page(s)

579-593

1 reference

The functional anatomy of basal ganglia disorders

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

Functional architecture of basal ganglia circuits: neural substrates of parallel processing

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

5-HT2 antagonist ritanserin in neuroleptic-induced parkinsonism: a double-blind comparison with orphenadrine and placebo.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

Effects of risperidone, clozapine and haloperidol on extracellular recordings of substantia nigra reticulata neurons of the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

Neuropharmacological studies on the nigro-striatal and raphe-striatal system in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

Indirect nucleus accumbens input to the prefrontal cortex via the substantia nigra pars reticulata: a combined anatomical and electrophysiological study in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

Alterations in extracellular and tissue levels of biogenic amines in rat brain induced by the serotonin2 receptor antagonist, ritanserin

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

Positron emission tomography studies on D2 and 5-HT2 receptor binding in risperidone-treated schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

Reduction of nigral glutamic acid decarboxylase in rats with neuroleptic-induced oral dyskinesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

Antidromic identification of dopaminergic and other output neurons of the rat substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

Molecular pharmacology and biology of 5-HT1C receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

Serotonin-dopamine interaction and its relevance to schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

8-OH-DPAT, a 5-HT1A agonist and ritanserin, a 5-HT2A/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

Risperidone in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

Role of substantia nigra pars reticulata neurons in the expression of neuroleptic-induced catalepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

Positron emission tomography finding of a high striatal D2 receptor occupancy in olanzapine-treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

Excitation of rat substantia nigra pars reticulata neurons by 5-hydroxytryptamine in vitro: evidence for a direct action mediated by 5-hydroxytryptamine2C receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

High-dose olanzapine for treatment-refractory schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

Basal ganglia GABAA and dopamine D1 binding site correlates of haloperidol-induced oral dyskinesias in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

Differential actions of serotonin, mediated by 5-HT1B and 5-HT2C receptors, on GABA-mediated synaptic input to rat substantia nigra pars reticulata neurons in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

The limbic functional selectivity of amperozide is not mediated by dopamine D2 receptors as assessed by in vitro and in vivo binding

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

Serotonin-dopamine interactions in the nigrostriatal system

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

Effects of muscimol and picrotoxin on single unit activity of substantia nigra neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

An open clinical and biochemical study of ritanserin in acute patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

On the significance of subterritories in the "accumbens" part of the rat ventral striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900094-4

7 January 2021

10.1016/S0278-5846(00)00094-4

Identifiers

DOI

1 reference

1 November 2017

1 reference